A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex

Ventilator-associated Bacterial Pneumonia Clinical Trial

Official title:
A Prospective, Multinational, Multicenter, Randomized, Sequential, Double-blind, Placebo-controlled, Phase 2a Clinical Trial to Assess the Safety and Pharmacokinetics of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex (ABC).

Status Not yet recruiting

Clinical Trial Summary

This is a phase 2a, multinational, multicenter, double-blind, randomized, placebo-controlled, dose-ranging safety, tolerability and PK study in patients with HABP (Hospital Acquired Bacterial Pneumonia) or VABP (Ventilator Associated Bacterial Pneumonia) caused by ABC to identify safe and well-tolerated doses and to assess the PK profile of OMN6 in patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hospital-acquired Bacterial Pneumonia
Pneumonia
Pneumonia, Bacterial
Ventilator-associated Bacterial Pneumonia

Clinical Trial Details

NCT number	NCT06087536
Study type	Interventional
Source	Omnix Medical Ltd
Contact	Bella Shusterman
Phone	+972 2 5320871
Email	bella@omnixmedical.com
Status	Not yet recruiting
Phase	Phase 2
Start date	January 2024
Completion date	June 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03894046` - Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex	Phase 3
Recruiting	`NCT05905055` - P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales	Phase 3
Completed	`NCT03583333` - Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)	Phase 3
Completed	`NCT02420366` - Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae
Completed	`NCT01292031` - Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)	Phase 3
Completed	`NCT02168946` - Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults	Phase 3
Completed	`NCT04107363` - Oropharyngeal Aspiration to Reduce Ventilator-Related Pneumonia	N/A
Not yet recruiting	`NCT01865266` - The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia	Phase 2/Phase 3
Withdrawn	`NCT03006679` - A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia	Phase 3